Re: ZE Slides Up

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: ZE Slides Up

in response to

Re: ZE Slides Up

tada

posted on Jan 08, 2019 06:06PM

Here is direct link to slides for Zenith's Biotech Showcase presentation. Slide 15 for abiraterone progressors indicates that data is through January 3, 2019....hot off the press. Slide 16 for enzalutamide progressors doesn't specify, but I assume is also through Jan 3.